Cellink AB (CLNK B):企業の財務・戦略的SWOT分析

◆英語タイトル:Cellink AB (CLNK B) - Financial and Strategic SWOT Analysis Review
◆商品コード:GDPH3446624FSA
◆発行会社(調査会社):GlobalData
◆発行日:2021年3月
◆ページ数:46
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:スウェーデン
◆産業分野:Pharmaceuticals and Healthcare
◆販売価格オプション(消費税別)
Site License(同一事業所内共有可)USD250 ⇒換算¥27,500見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥41,250見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Cellink AB (CLNK B) – Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Cellink AB (Cellink) develops and commercializes bioprinting technologies which enable researchers to print three dimensional (3D) human organs and tissues. The company’s product portfolio encompasses bioprinters which enable bioprinting of human tissues and tissue models for 3D culture in advanced research; and bioink, a biomaterial innovation that allows researchers to develop and grow 3D human cells to grow as they do in the natural human body environment. Cellink caters to research institutions, pharmaceutical, biopharmaceutical, automotive, and cosmetic companies. The company sells its products through direct sales force in the US and Sweden and through an extensive network of distributors in Europe (excluding Sweden), and Asia-Pacific. It operates a subsidiary in the US. Cellink AB is headquartered in Goteborg, Sweden.

Cellink AB Key Recent Developments

Mar 15,2021: Cellink launches the Bio Mdx Series, a scaled-up revolution in biomedical manufacturing
Mar 11,2021: Cellink announces an offering of Senior Unsecured Convertible Bonds convertible into Class B shares and a Class B share issue in an expected amount of SEK 2.75 billion
Feb 08,2021: CELLINK announce distribution agreement including new products for Single-Cell RNA Sequencing and NGS Library Preparation
Jan 28,2021: CELLINK announces third year extension of collaboration with a global biopharmaceutical company for drug discovery
Nov 27,2020: CELLINK welcomes new scientific advisor Professor Robert Langer from MIT and co-founder of Moderna

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
List of Tables
List of Figures
Section 1 – About the Company
Cellink AB – Key Facts
Cellink AB – Key Employees
Cellink AB – Key Employee Biographies
Cellink AB – Major Products and Services
Cellink AB – History
Cellink AB – Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 – Company Analysis
Company Overview
Cellink AB – Business Description
R&D Overview
Cellink AB – Corporate Strategy
Cellink AB – SWOT Analysis
SWOT Analysis – Overview
Cellink AB – Strengths
Cellink AB – Weaknesses
Cellink AB – Opportunities
Cellink AB – Threats
Cellink AB – Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Performance Chart
Financial Performance
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts
Section 4 – Company’s Lifesciences Financial Deals and Alliances
Cellink AB, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
Cellink AB, Pharmaceuticals & Healthcare, Deals By Type, 2015 to YTD 2021
Cellink AB, Recent Deals Summary
Section 5 – Company’s Recent Developments
Mar 15, 2021: Cellink launches the Bio Mdx Series, a scaled-up revolution in biomedical manufacturing
Mar 11, 2021: Cellink announces an offering of Senior Unsecured Convertible Bonds convertible into Class B shares and a Class B share issue in an expected amount of SEK 2.75 billion
Feb 08, 2021: CELLINK announce distribution agreement including new products for Single-Cell RNA Sequencing and NGS Library Preparation
Jan 28, 2021: CELLINK announces third year extension of collaboration with a global biopharmaceutical company for drug discovery
Nov 27, 2020: CELLINK welcomes new scientific advisor Professor Robert Langer from MIT and co-founder of Moderna
Oct 22, 2020: Cellink: Strong organic growth and important strategic acquisition under continued challenging conditions
Oct 21, 2020: CELLINK launches C.WASH, an innovative liquid handling system for automated media change in micro-well plates
Aug 28, 2020: CELLINK welcomes new scientific advisor Professor Ido Amit from the Weizmann Institute of Science
Jul 14, 2020: CELLINK and Kugelmeiers announce strategic partnership for 3D printing cell spheroids
Jul 09, 2020: Cellink – Q3 19/20: Continued growth and main market listing during an ongoing pandemic
Section 6 – Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

List of Tables
Cellink AB, Key Facts
Cellink AB, Key Employees
Cellink AB, Key Employee Biographies
Cellink AB, Major Products and Services
Cellink AB, History
Cellink AB, Other Locations
Cellink AB, Subsidiaries
Cellink AB, Key Competitors
Cellink AB, Ratios based on current share price
Cellink AB, Annual Ratios
Cellink AB, Annual Ratios (Cont...1)
Cellink AB, Annual Ratios (Cont...2)
Cellink AB, Interim Ratios
Cellink AB, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
Cellink AB, Pharmaceuticals & Healthcare, Deals By Type, 2015 to YTD 2021
Cellink AB, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

★海外企業調査レポート[Cellink AB (CLNK B):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Lam Research Corporation (LRCX):企業の財務・戦略的SWOT分析
    Lam Research Corporation (LRCX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weak …
  • Safaricom Ltd
    Safaricom Ltd - Strategy, SWOT and Corporate Finance Report Summary Safaricom Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • Johnson Controls International Plc (JCI):企業の財務・戦略的SWOT分析
    Johnson Controls International Plc (JCI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths …
  • Norfolk Southern Corp (NSC):企業の財務・戦略的SWOT分析
    Norfolk Southern Corp (NSC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • Bharti Airtel Limited:企業の戦略・SWOT・財務情報
    Bharti Airtel Limited - Strategy, SWOT and Corporate Finance Report Summary Bharti Airtel Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Cardiovascular Systems Inc (CSII):医療機器:M&Aディール及び事業提携情報
    Summary Cardiovascular Systems Inc (CSI) is a medical device company that develops and commercializes products for the treatment of peripheral and coronary vascular disease. The company's products include peripheral orbital atherectomy system, coronary orbital atherectomy system, crowns, and accesso …
  • Brown Brothers Harriman & Co:企業の戦略的SWOT分析
    Brown Brothers Harriman & Co - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major produc …
  • Starpharma Holdings Ltd (SPL):企業の財務・戦略的SWOT分析
    Starpharma Holdings Ltd (SPL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • Spicers Limited (SRS):企業の財務・戦略的SWOT分析
    Spicers Limited (SRS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Banco Bradesco S.A.:企業のM&A・事業提携・投資動向
    Banco Bradesco S.A. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Banco Bradesco S.A. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), …
  • Biocare Medical LLC:医療機器:M&Aディール及び事業提携情報
    Summary Biocare Medical LLC (Biocare) develops and supplies automated immunohistochemistry instrumentation and reagents. The company offers androgen receptor, amyloid A, estrogen receptor, ERG, factor xlla and folate receptor alpha IHC assay kit, among others. It offers on-site training, technical s …
  • International SOS Pte Ltd:企業の戦略的SWOT分析
    International SOS Pte Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …
  • Rinnai Corp (5947):企業の財務・戦略的SWOT分析
    Rinnai Corp (5947) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • Grupo Financiero Galicia S.A. (GGAL3):企業の財務・戦略的SWOT分析
    Grupo Financiero Galicia S.A. (GGAL3) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths an …
  • Kyowa Hakko Kirin Co., Ltd.:企業の戦略・SWOT・財務情報
    Kyowa Hakko Kirin Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary Kyowa Hakko Kirin Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Honkarakenne Oyj (HONBS):企業の財務・戦略的SWOT分析
    Honkarakenne Oyj (HONBS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • CEL-SCI Corp (CVM):製薬・医療:M&Aディール及び事業提携情報
    Summary CEL-SCI Corp (CEL-SCI) is a biotechnology company that carries out the research and development of new immunotherapy products for the treatment of various cancer and infectious diseases. Its core capabilities include drug discovery, research, development and manufacturing of compound biologi …
  • Berger Paints India Ltd (BERGEPAINT):企業の財務・戦略的SWOT分析
    Berger Paints India Ltd (BERGEPAINT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • LGC Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary LGC Ltd (LGC), formerly LGC (Teddington) Ltd is a life sciences measurement and testing company that offers reference materials, genomics solutions and analytical testing products and services. The company’s products comprise DNA extraction instrumentation, DNA extraction kits, Douglas scien …
  • Orkuveita Reykjavikur:電力:M&Aディール及び事業提携情報
    Summary Orkuveita Reykjavikur (Orkuveita) is a public utility company that provides electricity and water. The company generates and supplies electricity. It harnesses hot water from geothermal fields and supplies it for heating applications. The company also supplies cold water from its groundwater …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆